Transcatheter aortic valve implantation: current status and future perspectives
Tóm tắt
Từ khóa
Tài liệu tham khảo
Cribier, 2002, Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description, Circulation, 106, 3006, 10.1161/01.CIR.0000047200.36165.B8
Baumgartner, 2017, 2017 ESC/EACTS Guidelines for the management of valvular heart disease, Eur Heart J, 38, 2739, 10.1093/eurheartj/ehx391
Iung, 2005, Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?, Eur Heart J, 26, 2714, 10.1093/eurheartj/ehi471
Oguri, 2014, Clinical outcomes and safety of transfemoral aortic valve implantation under general versus local anesthesia, Circ Cardiovasc Interv, 7, 602., 10.1161/CIRCINTERVENTIONS.113.000403
de Brito, 2015, Outcomes and predictors of mortality after transcatheter aortic valve implantation: results of the Brazilian registry, Catheter Cardiovasc Interv, 85, E153, 10.1002/ccd.25778
Hyman, 2017, Conscious sedation versus general anesthesia for transcatheter aortic valve replacement, Circulation, 136, 2132, 10.1161/CIRCULATIONAHA.116.026656
Bartel, 2016, Intracardiac echocardiography for guidance of transcatheter aortic valve implantation under monitored sedation: a solution to a dilemma?, Eur Heart J Cardiovasc Imaging, 17, 1
Ludman, 2018
Ludman
Walther, 2015, Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry, J Am Coll Cardiol, 65, 2173, 10.1016/j.jacc.2015.03.034
Carroll, 2017, Procedural experience for transcatheter aortic valve replacement and relation to outcomes, J Am Coll Cardiol, 70, 29., 10.1016/j.jacc.2017.04.056
Auffret, 2017, Temporal trends in transcatheter aortic valve replacement in France: FRANCE 2 to FRANCE TAVI, J Am Coll Cardiol, 70, 42, 10.1016/j.jacc.2017.04.053
Shimura, 2017, Impact of the clinical frailty scale on outcomes after transcatheter aortic valve replacement, Circulation, 135, 2013., 10.1161/CIRCULATIONAHA.116.025630
Wood, 2017
Kamioka, 2018, Predictors and clinical outcomes of next-day discharge after minimalist transfemoral transcatheter aortic valve replacement, JACC Cardiovasc Interv, 11, 107, 10.1016/j.jcin.2017.10.021
Mylotte, 2013, Transcatheter aortic valve replacement in europe: adoption trends and factors influencing device utilization, J Am Coll Cardiol, 62, 210, 10.1016/j.jacc.2013.03.074
Hamm, 2016, The future of transcatheter aortic valve implantation, Eur Heart J, 37, 803, 10.1093/eurheartj/ehv574
Leon, 2016, Transcatheter or surgical aortic-valve replacement in intermediate-risk patients, N Engl J Med, 374, 1609, 10.1056/NEJMoa1514616
Reardon, 2017, Surgical or transcatheter aortic-valve replacement in intermediate-risk patients, N Engl J Med, 376, 1321, 10.1056/NEJMoa1700456
Smith, 2011, Transcatheter versus surgical aortic-valve replacement in high-risk patients, N Engl J Med, 364, 2187, 10.1056/NEJMoa1103510
Adams, 2014, Transcatheter aortic-valve replacement with a self-expanding prosthesis, N Engl J Med, 370, 1790, 10.1056/NEJMoa1400590
Siontis, 2016, Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials, Eur Heart J, 37, 3503, 10.1093/eurheartj/ehw225
Thourani, 2016, Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis, Lancet, 387, 2218, 10.1016/S0140-6736(16)30073-3
Thyregod, 2015, Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis, J Am Coll Cardiol, 65, 2184, 10.1016/j.jacc.2015.03.014
Yousaf, 2012, Prevalence of left ventricular dysfunction in a UK community sample of very old people: the Newcastle 85+ study, Heart, 98, 1418, 10.1136/heartjnl-2012-302457
Tarantini, 2003, Aortic valve replacement in severe aortic stenosis with left ventricular dysfunction: determinants of cardiac mortality and ventricular function recovery, Eur J Cardiothorac Surg, 24, 879, 10.1016/S1010-7940(03)00575-X
van Gils, 2017, Prognostic implications of moderate aortic stenosis in patients with left ventricular systolic dysfunction, J Am Coll Cardiol, 69, 2383, 10.1016/j.jacc.2017.03.023
Spitzer, 2016, Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial, Am Heart J, 182, 80, 10.1016/j.ahj.2016.08.009
Généreux, 2016, Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis, J Am Coll Cardiol, 67, 2263, 10.1016/j.jacc.2016.02.057
Pellikka, 2005, Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up, Circulation, 111, 3290, 10.1161/CIRCULATIONAHA.104.495903
Taniguchi, 2015, Initial surgical versus conservative strategies in patients with asymptomatic severe aortic stenosis, J Am Coll Cardiol, 66, 2827., 10.1016/j.jacc.2015.10.001
Lancellotti, 2012, Clinical outcome in asymptomatic severe aortic stenosis: insights from the new proposed aortic stenosis grading classification, J Am Coll Cardiol, 59, 235, 10.1016/j.jacc.2011.08.072
Maréchaux, 2010, Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis, Eur Heart J, 31, 1390, 10.1093/eurheartj/ehq076
Chamandi, 2017, Latest-generation transcatheter aortic valve replacement devices and procedures, Can J Cardiol, 33, 1082, 10.1016/j.cjca.2017.03.012
Husser, 2017, Multicenter comparison of novel self-expanding versus balloon-expandable transcatheter heart valves, JACC Cardiovasc Interv, 10, 2078., 10.1016/j.jcin.2017.06.026
Meredith Am, 2014, Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study, J Am Coll Cardiol, 64, 1339, 10.1016/j.jacc.2014.05.067
Liao, 2017, Transcatheter aortic valve implantation with the self-expandable venus A-Valve and CoreValve devices: preliminary experiences in China, Catheter Cardiovasc Interv, 89, 528, 10.1002/ccd.26912
Abdel-Wahab, 2014, Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the choice randomized clinical trial, JAMA, 311, 1503, 10.1001/jama.2014.3316
Feldman, 2018, Effect of mechanically expanded vs self-expanding transcatheter aortic valve replacement on mortality and major adverse clinical events in high-risk patients with aortic stenosis: the REPRISE III randomized clinical trial, JAMA, 319, 27, 10.1001/jama.2017.19132
Kappetein, 2012, Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2), Eur J Cardiothorac Surg, 42, S45, 10.1093/ejcts/ezs533
Capodanno, 2017, Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), Eur Heart J, 38, 3382, 10.1093/eurheartj/ehx303
Dvir, 2018, Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves, Circulation, 137, 388., 10.1161/CIRCULATIONAHA.117.030729
Bourguignon, 2015, Very long-term outcomes of the carpentier-edwards perimount valve in aortic position, Ann Thorac Surg, 99, 831, 10.1016/j.athoracsur.2014.09.030
David, 2010, Hancock II bioprosthesis for aortic valve replacement: the gold standard of bioprosthetic valves durability?, Ann Thorac Surg, 90, 775, 10.1016/j.athoracsur.2010.05.034
Arsalan, 2016, Durability of prostheses for transcatheter aortic valve implantation, Nat Rev Cardiol, 13, 360., 10.1038/nrcardio.2016.43
Mack, 2015, 5-Year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial, Lancet, 385, 2477, 10.1016/S0140-6736(15)60308-7
Del Trigo, 2016, Incidence, timing, and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: multicenter registry, J Am Coll Cardiol, 67, 644, 10.1016/j.jacc.2015.10.097
Makkar, 2015, Possible subclinical leaflet thrombosis in bioprosthetic aortic valves, N Engl J Med, 373, 2015, 10.1056/NEJMoa1509233
Fuchs, 2017, Subclinical leaflet thickening and stent frame geometry in self-expanding transcatheter heart valves, EuroIntervention, 13, e1067, 10.4244/EIJ-D-17-00373
Chakravarty, 2017, Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study, Lancet, 389, 2383, 10.1016/S0140-6736(17)30757-2
Werner, 2016, Incidence and clinical impact of stroke complicating transcatheter aortic valve implantation: results from the German TAVI Registry, Catheter Cardiovasc Interv, 88, 644, 10.1002/ccd.26612
Stortecky, 2012, Cerebrovascular accidents complicating transcatheter aortic valve implantation: frequency, timing and impact on outcomes, EuroIntervention, 8, 62, 10.4244/EIJV8I1A11
Kahlert, 2012, Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study, Circulation, 126, 1245., 10.1161/CIRCULATIONAHA.112.092544
Holmes, 2015, Clinical outcomes at 1 year following transcatheter aortic valve replacement, JAMA, 313, 1019, 10.1001/jama.2015.1474
Daneault, 2011, Stroke associated with surgical and transcatheter treatment of aortic stenosis: a comprehensive review, J Am Coll Cardiol, 58, 2143, 10.1016/j.jacc.2011.08.024
Haussig, 2016, Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the clean-tavi randomized clinical trial, JAMA, 316, 592, 10.1001/jama.2016.10302
Kapadia, 2017, Protection against cerebral embolism during transcatheter aortic valve replacement, J Am Coll Cardiol, 69, 367, 10.1016/j.jacc.2016.10.023
Seeger, 2017, Cerebral embolic protection during transfemoral aortic valve replacement significantly reduces death and stroke compared with unprotected procedures, JACC Cardiovasc Interv, 10, 2297, 10.1016/j.jcin.2017.06.037
Amat-Santos, 2012, Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation, J Am Coll Cardiol, 59, 178., 10.1016/j.jacc.2011.09.061
Auffret, 2016, Predictors of early cerebrovascular events in patients with aortic stenosis undergoing transcatheter aortic valve replacement, J Am Coll Cardiol, 68, 673, 10.1016/j.jacc.2016.05.065
Rodés-Cabau, 2017, Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve: the ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) randomized clinical trial, JACC Cardiovasc Interv, 10, 1357, 10.1016/j.jcin.2017.04.014
Ledwoch, 2013, Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation: analysis from the german transcatheter aortic valve interventions registry, Catheter Cardiovasc Interv, 82, E569, 10.1002/ccd.24915
Fadahunsi, 2016, Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: analysis from the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry, JACC Cardiovasc Interv, 9, 2189, 10.1016/j.jcin.2016.07.026
Nazif, 2015, Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry, JACC Cardiovasc Interv, 8, 60, 10.1016/j.jcin.2014.07.022
Regueiro, 2016, Impact of new-onset left bundle branch block and periprocedural permanent pacemaker implantation on clinical outcomes in patients undergoing transcatheter aortic valve replacement, Circ Cardiovasc Interv, 9, e003635., 10.1161/CIRCINTERVENTIONS.115.003635
Mohananey, 2017, Clinical and echocardiographic outcomes following permanent pacemaker implantation after transcatheter aortic valve replacement, Circ Cardiovasc Interv, 10, e005972., 10.1161/CIRCINTERVENTIONS.117.005972
Siontis, 2014, Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis, J Am Coll Cardiol, 64, 129, 10.1016/j.jacc.2014.04.033
Rampat, 2017, Conduction abnormalities and permanent pacemaker implantation after transcatheter aortic valve replacement using the repositionable LOTUS device: the United Kingdom experience, JACC Cardiovasc Interv, 10, 1247, 10.1016/j.jcin.2017.03.044
Keßler, 2017, Predictors of permanent pacemaker implantation after transfemoral aortic valve implantation with the Lotus valve, Am Heart J, 192, 57, 10.1016/j.ahj.2017.07.011
Fröhlich, 2015, Comparative survival after transapical, direct aortic, and subclavian transcatheter aortic valve implantation (data from the UK TAVI Registry), Am J Cardiol, 116, 1555, 10.1016/j.amjcard.2015.08.035
Greenbaum, 2014, Caval-aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients, J Am Coll Cardiol, 63, 2795., 10.1016/j.jacc.2014.04.015
Mylotte, 2014, Transcatheter aortic valve replacement in bicuspid aortic valve disease, J Am Coll Cardiol, 64, 2330., 10.1016/j.jacc.2014.09.039
Yoon, 2016, Transcatheter aortic valve replacement with early- and new-generation devices in bicuspid aortic valve stenosis, J Am Coll Cardiol, 68, 1195, 10.1016/j.jacc.2016.06.041
Yoon, 2017, Outcomes in transcatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis, J Am Coll Cardiol, 69, 2579, 10.1016/j.jacc.2017.03.017
Cahill, 2017, Challenges in infective endocarditis, J Am Coll Cardiol, 69, 325, 10.1016/j.jacc.2016.10.066
Latib, 2014, TAVR-associated prosthetic valve infective endocarditis: results of a large, multicenter registry, J Am Coll Cardiol, 64, 2176, 10.1016/j.jacc.2014.09.021
Regueiro, 2016, Association between transcatheter aortic valve replacement and subsequent infective endocarditis and in-hospital death, JAMA, 316, 1083, 10.1001/jama.2016.12347
Miyazaki, 2017, Acute performance of a novel restorative transcatheter aortic valve: preclinical results, EuroIntervention, 13, e1410, 10.4244/EIJ-D-17-00554
Chambers, 2015, Standards for heart valve surgery in a ‘Heart Valve Centre of Excellence’, Open Heart, 2, e000216., 10.1136/openhrt-2014-000216
Eggebrecht, 2016, Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919 patients, Eur Heart J, 37, 2240, 10.1093/eurheartj/ehw190
Bestehorn, 2017, Volume-outcome relationship with transfemoral transcatheter aortic valve implantation (TAVI): insights from the compulsory German Quality Assurance Registry on Aortic Valve Replacement (AQUA), EuroIntervention, 13, 914, 10.4244/EIJ-D-17-00062
Nimptsch, 2017, Hospital volume and mortality for 25 types of inpatient treatment in German hospitals: observational study using complete national data from 2009 to 2014, BMJ Open, 7, e016184., 10.1136/bmjopen-2017-016184
d'Arcy, 2016, Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study, Eur Heart J, 37, 3515, 10.1093/eurheartj/ehw229